Cromolyn (cromoglicate) reduces levels of the Alzheimer’s disease-associated amyloid β-protein by promoting microglial phagocytosis [Nature Sci Rep., Jan 2018 — free full-text] User isosafrole, in the pharmacology subreddit, 25 Nov 2018